Evidence map›Paper›PMID 40826360›Full record

ArticleCardiovascular diabetology2025

Prognostic value of triglyceride-glucose index combined with stress hyperglycemia ratio for all-cause mortality in critically ill patients with stroke.

Tengli Li, Zhiheng Yi, Yangshen Huang, Yuhan Tan, Shan Gao, Tingting Wang, Shaowei Guo

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tengli LiDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Zhiheng YiDepartment of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong Province, China.
Yangshen HuangDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Yuhan TanDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Shan GaoDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Tingting WangDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China. wttsumc@stu.edu.cn.ORCID 0000-0002-3648-4284
Shaowei GuoDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China. 07swguo1@stu.edu.cn.ORCID 0000-0002-3662-0290

Funding

First Affiliated Hospital of SUMC Scientific Research Initiation Grant 20210930038Guangdong Basic and Applied Research Foundation 2021A1515110873Guangdong Basic and Applied Research Foundation 2022A1515110139Guangdong Provincial Natural Science Foundation 2024A1515013012National Natural Science Foundation of China 82201511Postdoctoral Research Initiation Grant 202205230031-3SUMC Scientific Research Initiation Grant 009-510858038
6 · The paper itself

Abstract

backgroundThe triglyceride-glucose (TyG) index and stress hyperglycemia ratio (SHR) are emerging biomarkers in cerebrovascular diseases, but their combined prognostic value for mortality in patients with critically ill stroke remains unexplored. This study, based on a cohort of critically ill patients with stroke, aims to investigate the prognostic value of the combined TyG index and SHR in predicting all-cause mortality at multiple time points in this high-risk population.

methodsBased on the Medical Information Mart for Intensive Care (MIMIC)-IV database, 2998 critically ill patients with stroke requiring intensive care unit (ICU) admission were included. Patients were stratified into 8 groups based on the median of the TyG index and the quartiles of the SHR. The primary outcomes were 30-day and 365-day all-cause mortality; the secondary outcomes included 90-day and 180-day mortality. Cox proportional hazards regression models, restricted cubic splines (RCS) curves, subgroup analyses, and mediation analyses were employed to assess associations between the combined TyG index and SHR with all-cause mortality.

resultsThe cohort had a median age of 72.63 years (IQR 61.27-82.69 years), with 51.33% male (1539/2998). Fully adjusted Cox proportional hazards models showed that compared to the reference group (TyG < 8.72 and SHR < 0.86), patients with TyG ≥ 8.72 and SHR ≥ 1.18 had the highest mortality risk (30-day HR 2.481, 95% CI 1.767-3.485; 365-day HR 1.954, 95% CI 1.532-2.493). RCS analysis confirmed linear positive correlations between the TyG index, SHR, and mortality at all time points (all P for non-linearity > 0.05). Subgroup analyses further demonstrated consistent associations between the combined TyG index and SHR on 30-day and 365-day all-cause mortality. Mediation analysis revealed that the highest SHR significantly mediated the association between high TyG and mortality in these patients (30-day mediation proportion: 48.82%, P = 0.024; 365-day: 22.93%, P = 0.004).

conclusionThe combination of high TyG (≥ 8.72) and elevated SHR (≥ 1.18) is significantly associated with increased short- and long-term mortality in critically ill patients with stroke. Integrated metabolic monitoring and early intervention targeting at these biomarkers may improve their prognosis.

Indexed as

Blood GlucoseHyperglycemiaStress, PhysiologicalStrokeTriglyceridesAgedAged, 80 and overBiomarkersCause of DeathCritical IllnessDatabases, FactualFemaleHumansMaleMiddle AgedPredictive Value of TestsBiomarkersBlood GlucoseTriglyceridesMIMIC-IVMortalityStress hyperglycemia ratioStrokeTriglyceride-glucose index

Identifiers

PMID40826360
PMCPMC12362854

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.